Figure 1.
Progression-free survival of the 822 NMIBC according to CD3G-rs3212262 genotypes. Five-year progression-free survival was 92% for AA, 85% for Aa, and 71% for aa genotypes (log-rank P = 8.4 × 10−4, adjusted Cox P = 0.023).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.